1. Home
  2. MYSZ vs SNGX Comparison

MYSZ vs SNGX Comparison

Compare MYSZ & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo My Size Inc.

MYSZ

My Size Inc.

HOLD

Current Price

$0.88

Market Cap

3.8M

Sector

Technology

ML Signal

HOLD

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$1.36

Market Cap

14.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYSZ
SNGX
Founded
1999
1987
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
14.4M
IPO Year
N/A
1987

Fundamental Metrics

Financial Performance
Metric
MYSZ
SNGX
Price
$0.88
$1.36
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
268.3K
314.9K
Earning Date
11-14-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,512,000.00
N/A
Revenue This Year
$18.06
N/A
Revenue Next Year
$36.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$1.09
52 Week High
$3.15
$6.23

Technical Indicators

Market Signals
Indicator
MYSZ
SNGX
Relative Strength Index (RSI) 47.98 48.51
Support Level $0.79 $1.33
Resistance Level $1.22 $1.42
Average True Range (ATR) 0.07 0.08
MACD 0.02 0.00
Stochastic Oscillator 24.91 47.19

Price Performance

Historical Comparison
MYSZ
SNGX

About MYSZ My Size Inc.

My Size Inc is a USA-based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers and licensing cloud-enabled software subscriptions, associated software maintenance, and support.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: